Biosketch / Results /

Kenneth Washenik

Clinical Assistant Professor, Ronald O. Perelman Department of Dermatology

Contact Info

Kenneth.WashenikAMD@nyumc.org

Education

1991-1994 — NYU Medical Center (Dermatology), Residency Training

Research Interests

Phase I, II, III and Post-marketing Clinical Studies on all aspects of dermatologic disease (inflammatory, infectious and neoplastic) including HIV related disorders and wound healing.

Future horizons in hair restoration
Marshall, Bryan T; Ingraham, Chris A; Wu, Xunwei; Washenik, Ken. Future horizons in hair restoration. Facial plastic surgery clinics of North America. 2013 Aug ;21(3):521-528 (550062)

Comparison of tazarotene and minocycline maintenance therapies in acne vulgaris: a multicenter, double-blind, randomized, parallel-group study
Leyden, James; Thiboutot, Diane M; Shalita, Alan R; Webster, Guy; Washenik, Kenneth; Strober, Bruce E; Shupack, Jerome. Comparison of tazarotene and minocycline maintenance therapies in acne vulgaris: a multicenter, double-blind, randomized, parallel-group study. Archives of dermatology (1960). 2006 May ;142(5):605-612 (94895)

Topical retinoids in inflammatory acne: A retrospective, investigator-blinded, vehicle-controlled, photographic assessment
Leyden, JJ; Shalita, A; Thiboutot, D; Washenik, K; Webster, G. Topical retinoids in inflammatory acne: A retrospective, investigator-blinded, vehicle-controlled, photographic assessment. Clinical therapeutics. 2005 FEB ;27(2):216-224 (50164)

Evaluation and treatment of male and female pattern hair loss
Olsen, Elise A; Messenger, Andrew G; Shapiro, Jerry; Bergfeld, Wilma F; Hordinsky, Maria K; Roberts, Janet L; Stough, Dow; Washenik, Ken; Whiting, David A. Evaluation and treatment of male and female pattern hair loss. Journal of the American Academy of Dermatology. 2005 Feb ;52(2):301-311 (67509)

Etanercept does not effectively treat moderate to severe alopecia areata: an open label study
Strober, BE; Siu, K; Alexis, AF; Kim, G; Washenik, K; Sinha, A; Shupack, JL. Etanercept does not effectively treat moderate to severe alopecia areata: an open label study [Meeting Abstract]. Journal of investigative dermatology. 2005 ;125(1):940-940 (104636)